Metrics
- Price
- $6.89
- Market Cap $M
- 85
- Rel Volume
- 1.98
- Vol Up 2W
- 22.2%
- Vol Trend 2W
- +121.5%
- 1D
- +0.3%
- 1W
- -1.6%
- 1M
- +35.9%
- 1M Slope
- +49.8%
- 6M Range
- 195.5%
- Score
- 78.3
- Sharp
- 0.0
Volume
Profile
Lixte Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies based on novel protein phosphatase inhibitor compounds.
Biotech
Pharmaceuticals